Drug Delivery: Surveying the global competitive
landscape is a new (March 2013) richly-detailed report which examines, in
depth, 106 leading and emerging specialist drug delivery companies. The report
covers all major technology areas including controlled-release, nucleic acid,
nano-enabled and targeted delivery.
The importance of drug-delivery technology grows
ever more apparent and commercial and pharma industry interest continues to
build. The new biologic products which are coming to market are widening the
demand for novel delivery targeted mechanisms. Controlled-release technologies
continue to play a crucial role in a product’s life-cycle and the pharma
industry is able to extend patent protection and preserve revenues.
The emerging biosimilars market offers great
potential for developers of targeted delivery as a range of high-value brands
such as Roche’s Herceptin and Avastin will be subject to patent challenges in
the coming years. With many biosimilars planned or already in development
around the world, the need for novel delivery mechanisms will increase.
This
report provides you with key data for each company.
- Company Overview & Technology Focus
- Key Personnel
- Key Milestones
- Products/Technologies
- Research Activities
- Key Agreements & Alliances
- Financial Data (where available)
- Contact Details
The ability to readily assess the companies
involved, compare areas of research interest, profile products being developed,
identify strategic collaborations and evaluate performance/funding is key to
understanding this market. In 716 information-packed pages, this new report
Drug Delivery: Surveying the global competitive landscape (published March
2013) evaluates companies large and small from multinationals to specialist
development and technology organisations.
Inquire
For Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=84925
Related
Publications
Drug
Delivery Insight
Whether your interest is commercial, financial, scientific or technological, no other business publication comes close to Drug Delivery Insight for providing such a comprehensive overview of the latest developments in every area of drug delivery. Available in print or updated regularly online.
Whether your interest is commercial, financial, scientific or technological, no other business publication comes close to Drug Delivery Insight for providing such a comprehensive overview of the latest developments in every area of drug delivery. Available in print or updated regularly online.
Emerging
Drug Delivery Technologies & Strategies: Players, Pipelines and
Partnerships
This 3-volume 185-page report is essential for commercial business analysts, research planners and new product development specialists. Anyone who needs to understand the future outlook for, and competitive environment in, the global drug delivery market will benefit.
This 3-volume 185-page report is essential for commercial business analysts, research planners and new product development specialists. Anyone who needs to understand the future outlook for, and competitive environment in, the global drug delivery market will benefit.
Drug
Delivery Technologies: Advanced Oral & Parenteral
This major 2-volume report is essential reading for everyone in the drug delivery field, from niche technology specialists in the investment community and the pharmaceutical industry.
This major 2-volume report is essential reading for everyone in the drug delivery field, from niche technology specialists in the investment community and the pharmaceutical industry.
Medical
Device Companies Analysis
A unique reporting service providing a complete appraisal of leading medical device companies worldwide, from 5-year financial review to analysis of significant strategic alliances and research portfolios.
A unique reporting service providing a complete appraisal of leading medical device companies worldwide, from 5-year financial review to analysis of significant strategic alliances and research portfolios.
This
report details some of the most exciting technology out there and the companies
involved
Web
access included at no additional cost!
No comments:
Post a Comment
Note: only a member of this blog may post a comment.